Skip to content

Erasca, Inc. ERAS Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.85B+8.4%
Eli Lilly logo
Eli LillyLLY
$4.09B+78.5%
Pfizer logo
PfizerPFE
$14.2B+6.8%
Amgen logo
AmgenAMGN
$2.37B+7.0%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$6.88M+66.2%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$119M-28.3%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$4.69B+1,196%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Erasca, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Erasca, Inc.'s other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Erasca, Inc.'s other non-current liabilities?
Erasca, Inc. (ERAS) reported other non-current liabilities of $340K in Q1 2026.
How has Erasca, Inc.'s other non-current liabilities changed year-over-year?
Erasca, Inc.'s other non-current liabilities increased by 35.5% year-over-year, from $251K to $340K.
What is the long-term trend for Erasca, Inc.'s other non-current liabilities?
Over 4 years (2021 to 2025), Erasca, Inc.'s other non-current liabilities has grown at a 26.1% compound annual growth rate (CAGR), from $158K to $399K.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.